Thursday, December 29, 2016

TRADE IDEA ON YESBANK FUTURE FOR 30 DEC 2016

“BUY YESBANK ABOVE 1140 TGT 1165/1180 SL 1110”
FOR MORE CALLS FILL UP THE FORM GIVEN HERE>>>>>
After showing correction from the higher level, now stock is trading in short term recovery phase, it is likely to continue the upside move in near term with the crossing of the resistance level of 1140 as the stock is managing to sustain above the level of 1150. One may get the targets of 1165,1200 in the stock with the stop loss of 1110.

NIFTY SETTLES ABOVE 8,100, SENSEX GAINS 155 POINTS

The Sensex ended with a gain of 155 points at 26,366. The  Sensex opened at 26,429 touched an intra-day high of 26,430 and low of 26,168.The Nifty closed with a gain of 69 points at 8,104. The  Nifty opened at 8,031 hitting a high of 8,111 and low of 8,021. The Sensex and Nifty recovered from recent losses to close at their highest in more than one week on Thursday, after a volatile trading session ahead of the expiry of monthly derivative contracts.The Nifty started the December derivatives expiry session at 8,028 and recorded an intra-day low at 8,025 levels. Subsequently, witnessing buying interest, the contract entered the positive territory by breaching the immediate resistance at 8,031. The contract marked an intra-day high at 8,109.Conversely, the Nifty can bring back selling pressure on a strong slump below 8,025.                                                                          
           Technically,
Traders can go long at every dip in the market with strict stoploss at 7893 levels on closing basis. On the other hand, if the nifty reverses lower from 8,025 a corrective fall to 7970 or 7950 is possible.  and downside be alert below 7990 and avoid all longs below that level as selling may intensify below that level. Next key supports below 8,025 are at 8,000 and 7,980 levels. And the resistance to the up move is at 8120-8150-8170-8200 levels.
TOP GAINERS:  Grasim, Yes Bank, BPCL, Eicher Motors, Bosch, Tata Motors DVR,
TOP LOSERS:  Adani Ports, Sun Pharmaceuticals, Aurobindo Pharma, Infosys, L&T, 

No comments:

Post a Comment